Determination of binding constant of DNA-binding drug to target DNA by surface plasmon resonance biosensor technology

Current Drug Targets: Immune, Endocrine and Metabolic Disorders

Volumn 5, Issue 1, 2005, Pages 61-72

  Lin, Liang Ping ^a   Huang, Long Sun ^b   Lin, Chii Waan ^a   Lee, Chi Kung ^b   Chen, Ji Liang ^a   Hsu, Su Ming ^a   Lin, Shiming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Binding constant; Binding ratio; DNA binding drug; Stoichiometry; Surface plasmon resonance; Target DNA

Indexed keywords

2,5 BIS(4 AMIDINOPHENYL)FURAN; ACRIDINE DERIVATIVE; ANTIINFECTIVE AGENT; AT 2433 B1; CARBAZOLE DERIVATIVE; DACTINOMYCIN; DB 293; DB 358; DIAMIDINE DERIVATIVE; DISTAMYCIN A; DITERCALINIUM; DNA; DNA TOPOISOMERASE; FURIMIDAZOLINE; MITHRAMYCIN; THIOPHENE DERIVATIVE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BINDING AFFINITY; BIOSENSOR; DNA BINDING; DNA CLEAVAGE; DNA DETERMINATION; DNA FOOTPRINTING; DNA SEQUENCE; DRUG BINDING; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; ENZYME ACTIVITY; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PROTEIN DNA INTERACTION; RESTRICTION MAPPING; REVIEW; STEADY STATE; STOICHIOMETRY; STRUCTURE ANALYSIS; SURFACE PLASMON RESONANCE;

ANIMALS; BINDING SITES; DNA; DRUG DELIVERY SYSTEMS; HUMANS; PHARMACEUTICAL PREPARATIONS; SURFACE PLASMON RESONANCE;

EID: 15444373430     PISSN: 15680088     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568008053174697     Document Type: Review

References (37)

1. Tanious, F.A.; Ding, D; Patrick, D.A.; Bailly, C.; Tidwell, R.R. and Wilson, W.D. (2000) Biochemistry, 39(39), 12091-12101.
2. Wang, L.; Bailly, C.; Kumar, A.; Ding, D; Bajic, M.; Boykin, D.W. and Wilson, W.D. (2000) Proc. Natl. Acad. Sci. USA, 97 1), 12-16.
3. Tanious, F.A.; Wilson, W.D.; Patrick, D.A.; Tidwell, R.R.; Colson, P.; Houssier, C.; Tardy, C. and Bailly, C. (2001) Eur. J. Biochem., 268(12), 3455-3464.
4. Bailly, C.; Tardy, C.; Wang, L.; Armitage, B.; Hopkins, K.; Kumar, A.; Schuster, G.B.; Boykin, D.W. and Wilson, W.D. (2001) Biochemistry, 40(33), 9770-9779.
5. Bilik, P.; Tanious, F.; Kumar, A.; Wilson, W.D.; Boykin, D.W.; Colson, P.; Houssier, C.; Facompre, M.; Tardy, C. and Bailly, C. (2001) Chembiochem., 2(7-8), 559-569.
6. Wang, L.; Carrasco, C.; Kumar, A.; Stephens, C.E.; Bailly, C.; Boykin, D.W. and Wilson, W.D. (2001) Biochemistry, 40(8), 2511-2521.
7. Nguyen, B.; Tardy, C.; Bailly, C.; Colson, P.; Houssier, C.; Kumar, A.; Boykin, D.W. and Wilson, W.D. (2002) Biopolymers, 63 5), 281-297.
8. Carrasco, C.; Rosu, F.; Gabelica, V.; Houssier, C.; Pauw, E.D.; Garbay-Jaureguiberry, C.; Roques, B.; Wilson, W.D.; Chaires, J.B.; Waring, M.J. and Bailly, C. (2002) Chembiochem., 3(12), 1235-1241.
9. Carrasco, C.; Facompré, M.; Chisholm, J.D.; Vranken, D.L.V.; Wilson, W.D. and Bailly, C. (2002) Nucleic Acids Res., 30(8), 1774-1781.
10. Teulade-Fichou, M.P.; Carrasco, C.; Guittat, L.; Bailly, C.; Alberti, P.; Mergny, J.L.; David, A.; Lehn, J.M. and Wilson, W.D. (2003) J. Am. Chem. Soc., 125(16), 4732-4740.
11. Davidson, M. (1992) Spectroscopy, 7(1), 32-36.
12. Feriotto, G.; Ciucci, A.; Mischiati, C.; Animati, F.; Lombardi, P.; Giacomini, P. and Gambari, R. (1994a) Eur. J. Pharmacol. 267(2), 143-149.
13. Mischiati, C.; Borgatti, M. and Bianchi, N. (1999) J. Biol. Chem., 274(46), 33114-33122.
14. Agbandje, M. and McKenna, R. (1992) In Nucleic Acid Targeted Drug Design, (Propst, C.L. and Perun, T.J., Ed.), Marcel Dekker, New York, pp. 525-551.
15. Dabrowiak, J.C.; Stankus, A.A. and Goodisman, J. (1992) In Nucleic Acid Targeted Drug Design, (Propst, C.L. and Perun, T.J., Ed.), Marcel Dekker, New York, pp. 128.
16. Davies, J. (1994) Nanobiology, 3(1), 5-16.
17. Markey, F. (1999) BIA J., 6(1), 14-17.
18. Lackmann, M.; Bucci, T.; Mann, R.J.; Kravets, L.A.; Viney, E.; Smith, F.; Moritz, R.L.; Carter, W.; Simpson, R.J. and Nicola, N.A. (1996) Proc. Natl. Acad. Sci. USA, 93(6), 2523-2527.
19. Myszka, D.G. (1999) J. Mol. Recognit., 12(6), 390-408.
20. Rich, R.L. and Myszka, D.G. (2000) Curr. Opin. Biotech. 11(1), 54-61.
21. Markgren, P.-O.; Hämäläinen, M. and Danielson, U. (1999) Anal. Biochem., 265(2), 340-350.
22. Morton, T.A. and Myszka, D.G. (1998) Methods Enzymol., 295, 268-294.
23. Myszka, D.G.; Jonsen, M.D. and Graves, B.J. (1998) Anal. Biochem., 265(2), 326-330.
24. Zeder-Lutz, G.; Neurath, A.R. and Van Regenmortel, M.H. (1999) Biologicals, 27(1), 29-34.
25. Roos, H.; Karlsson, R.; Nilshans, H. and Persson, A. (1998) J. Mol. Recognit., 11(1-6), 204-210.
26. Gambari, R.; Feriotto, G.; Rutigliano, C.; Bianchi, N. and Mischiati, C. (2000) J. Pharmacol. Exp. Ther., 294(1), 370-377.
27. Ciolkowski, M.L.; Fang, M.M. and Lund, M.E. (2000) J. Pharm. Biomed. Anal., 22(6), 1037-1045.
28. Boger, D.L. and Saionz, K.W. (1999) Bioorg. Med. Chem., 7(2), 315-321.
29. Read, M.; Harrison, R.J.; Romagnoli, B.; Tanious, F.A.; Gowan, S.H.; Reszka, A.P.; Wilson, W.D.; Kelland, L.R. and Neidle S. (2001) Proc. Natl. Acad. Sci. USA, 98(9), 4844-4849.
30. Glaser, R.W. (1993) Analyt. Biochem., 213(1), 152-161.
31. Jonsson, U.; Fagerstam, L.; Ivarsson, B.; Johnsson, B. and Karlsson, R. (1991) Biotechniques, 11(5), 620-627.
32. Vadgama, P. and Crump, P.W. (1992) Analyst, 117 11), 1657-1670.
33. Malmqvist, M. (1993) Nature (Lond), 361(6408), 186-187.
34. Persson, B.; Stenhag, K.; Nilsson, P.; Larsson, A.; Uhle'n, M. and Nygren, P. (1997) Anal. Biochem., 246(1), 34-44.
35. Chen, F.M. (1988) Biochemistry, 27(17), 6393-6397.
36. Chen, F.M. (1992) Biochemistry, 31(27), 6223-6228.
37. Mazur, S.; Tanious, F.A.; Ding, D.; Kumar, A.; Boykin, D.W.; Simpson, I.J.; Neidle, S. and Wilson, W.D. (2000) J. Mol. Biol., 300(2), 321-337.